Abstract
Diabetes mellitus is a leading cause of morbidity and mortality in the Western world. Currently, the only forms of β-cell replacement are whole organ pancreas transplantation and pancreatic islet transplantation. Whole organ transplantation has demonstrated benefits in prevention and reversal of diabetic complications with sustainable long-term outcomes. Pancreatic islet transplantation continues to be a field that needs further study to ascertain the true benefit of islet transplantation for diabetic complications. This can only be achieved with improvement in long-term islet allograft survival.
Similar content being viewed by others
References and Recommended Reading
Centers for Disease Control and Prevention: National estimates on diabetes. http://www.cdc.gov/diabetes/pubs/ estimates05.htm. Accessed April 4, 2006.
Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group [no authors listed]. N Engl J Med 2000, 342:381–389. Large multicenter study that demonstrated the importance of normoglycemia through intensive insulin therapy to prevent progression of diabetic retinopathy and diabetic nephropathy.
Shapiro AM, Lakey JR, Ryan EA, et al.: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000, 343:230 -238. The initial description of an immunosuppressive and islet transplant regiment that allowed for insulin independence after PIT. This paper was a novel breakthrough that has allowed for the rapid expansion of PIT.
Kelly WD, Lillehei RC, Merkel FK, et al.: Allotransplantation of the pancreas nad duodenum along with the kidney in diabetic nephropathy. Surgery 1967, 61:827–837.
Gruessner AC, Sutherland DE: Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant 2005, 19:433–455.
Schena FP, Gesualdo L: Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol 2005, 16(suppl 1):S30-S33.
Fioretto P, Steffes MW, Sutherland DE, et al.: Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998, 339:69–75. Paper describes the definitive long-term benefit (10-year follow-up) of whole organ pancreas transplantation on diabetic end-organ disease.
Coppelli A, Giannarelli R, Vistoli F, et al.: The beneficial effects of pancreas transplant alone on diabetic nephropathy. Diabetes Care 2005, 28:1366–1370.
Larsen JL: Pancreas transplantation: indications and consequences. Endocr Rev 2004, 25:919–946.
Giannarelli R, Coppelli A, Sartini M, et al.: Effects of pancreas-kidney transplantation on diabetic retinopathy. Transpl Int 2005, 18:619–622.
Koznarova R, Saudek F, Sosna T, et al.: Beneficial effect of pancreas and kidney transplantation on advanced diabetic retinopathy. Cell Transplant 2000, 9:903–908.
Perkins BA, Bril V: Diagnosis and management of diabetic neuropathy. Curr Diab Rep 2002, 2:495–500.
Gaber AO, Oxley D, Karas J, et al.: Changes in gastric emptying in recipients of successful combined pancreaskidney transplants. Dig Dis 1991, 9:437–443.
Gaber AO, el-Gebely S, Sugathan P, et al.: Early improvement in cardiac function occurs for pancreas-kidney but not diabetic kidney-alone transplant recipients. Transplantation 1995, 59:1105–1112.
Navarro X, Sutherland DE, Kennedy WR: Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol 1997, 42:727–736.
Martinenghi S, Comi G, Galardi G, et al.: Amelioration of nerve conduction velocity following simultaneous kidney/ pancreas transplantation is due to the glycemic control provided by the pancreas. Diabetologia 1997, 40:1110–1112.
Senior PA, Welsh RC, McDonald CG, et al.: Coronary artery disease is common in nonuremic, asymptomatic type 1 diabetic islet transplant candidates. Diabetes Care 2005, 28:866–872.
La Rocca E, Fiorina P, di Carlo V, et al.: Cardiovascular outcomes after kidney-pancreas and kidney-alone transplantation. Kidney Int 2001, 60:1964–1971.
Coppelli A, Giannarelli R, Mariotti R, et al.: Pancreas transplant alone determines early improvement of cardiovascular risk factors and cardiac function in type 1 diabetic patients. Transplantation 2003, 76:974–976.
Fiorina P, La Rocca E, Venturini M, et al.: Effects of kidneypancreas transplantation on atherosclerotic risk factors and endothelial function in patients with uremia and type 1 diabetes. Diabetes 2001, 50:496–501.
Biesenbach G, Konigsrainer A, Gross C, Margreiter R: Progression of macrovascular diseases is reduced in type 1 diabetic patients after more than 5 years successful combined pancreas-kidney transplantation in comparison to kidney transplantation alone. Transpl Int 2005, 18:1054–1060.
Ballinger WF, Lacy PE: Transplantation of intact pancreatic islets in rats. Surgery 1972, 72:175–186.
Shapiro AM, Lakey JR, Paty BW, et al.: Strategic opportunities in clinical islet transplantation. Transplantation 2005, 79:1304–1307.
Goss JA, Soltes G, Goodpastor SE, et al.: Pancreatic islet transplantation: the radiographic approach. Transplantation 2003, 76:199–203.
Ha.z MM, Faradji RN, Froud T, et al.: Immunosuppression and procedure-related complications in 26 patients with type diabetes mellitus receiving allogeneic islet cell transplantation. Transplantation 2005, 80:1718–1728.
Barshes NR, Lee TC, Goodpastor SE, et al.: Transaminitis after pancreatic islet transplantation. J Am Coll Surg 2005, 200:353–361.
Rafael E, Ryan EA, Paty BW, et al.: Changes in liver enzymes after clinical islet transplantation. Transplantation 2003, 76:1280–1284.
Goss JA, Goodpastor SE, Brunicardi FC, et al.: Development of a human pancreatic islet-transplant program through a collaborative relationship with a remote islet-isolation center. Transplantation 2004, 77:462–466.
Barshes NR, Lee T, Goodpasture S, et al.: Achievement of insulin independence via pancreatic islet transplantation using a remote isolation center: a first-year review. Transplant Proc 2004, 36:1127–1129.
Ryan EA, Paty BW, Senior PA, et al.: Five-year follow-up after clinical islet transplantation. Diabetes 2005, 54:2060–2069. The first description of long-term patient data on PIT since the introduction of the Edmonton protocol.
Hering BJ: Achieving and maintaining insulin independence in human islet transplant recipients. Transplantation 2005, 79:1296–1297.
Fiorina P, Folli F, Zerbini G, et al.: Islet transplantation is associated with improvement of renal function among uremic patients with type I diabetes mellitus and kidney transplants. J Am Soc Nephrol 2003, 14:2150–2158.
Fiorina P, Gremizzi C, Maf P, et al.: Islet transplantation is associated with an improvement of cardiovascular function in type 1 diabetic kidney transplant patients. Diabetes Care 2005, 28:1358–1365.
Lee TC, Barshes NR, O'Mahony CA, et al.: The effect of pancreatic islet transplantation on progression of diabetic retinopathy and neuropathy. Transplant Proc 2005, 37:2263–2265.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, T.C., Barshes, N.R., Agee, E.E. et al. The effect of whole organ pancreas transplantation and pit on diabetic complications. Curr Diab Rep 6, 323–327 (2006). https://doi.org/10.1007/s11892-006-0068-x
Issue Date:
DOI: https://doi.org/10.1007/s11892-006-0068-x